European Medicines Agency clarifies opinion on pioglitazone and the risk of bladder cancer

View source ↗

Summary

The EMA clarifies its opinion regarding pioglitazone and the risk of bladder cancer, addressing safety concerns and regulatory stance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)